BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 7004618)

  • 1. Treatment of acute renal failure due to myeloma kidney.
    Bear RA; Cole EH; Lang A; Johnson M
    Can Med Assoc J; 1980 Oct; 123(8):750-3. PubMed ID: 7004618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic dialysis in patients with multiple myeloma and renal failure: a worthwhile treatment.
    Iggo N; Palmer AB; Severn A; Trafford JA; Mufti GJ; Taube D; Parsons V
    Q J Med; 1989 Oct; 73(270):903-10. PubMed ID: 2629022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development and treatment of renal insufficiency in multiple myeloma].
    Mølby L; Hansen HH; Jensen EL
    Ugeskr Laeger; 1994 Jul; 156(30):4343-7. PubMed ID: 8066935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe renal failure in multiple myeloma.
    Cosio FG; Pence TV; Shapiro FL; Kjellstrand CM
    Clin Nephrol; 1981 Apr; 15(4):206-10. PubMed ID: 7237869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Successful haemodialysis treatment of acute renal failure in a patient with multiple myeloma (author's transl)].
    Kopsa H; Schmidt P; Zazgornik J; Balcke P; Deutsch E
    Med Klin; 1978 May; 73(18):668-70. PubMed ID: 651757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Survival of myeloma patients treated with dialysis].
    Martín Reyes G; Valera A; Frutos MA; Ramos B; Ordóñez V; López de Novales E
    Nefrologia; 2003; 23(2):131-6. PubMed ID: 12778877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dialysis-dependent renal failure in patients with myeloma can be reversed by high-dose myeloablative therapy and autotransplant.
    Lee CK; Zangari M; Barlogie B; Fassas A; van Rhee F; Thertulien R; Talamo G; Muwalla F; Anaissie E; Hollmig K; Tricot G
    Bone Marrow Transplant; 2004 Apr; 33(8):823-8. PubMed ID: 14767499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors and effectiveness of treatment in acute renal failure due to multiple myeloma: a review of 50 cases. Report of the Italien Renal Immunopathology Group.
    Pozzi C; Pasquali S; Donini U; Casanova S; Banfi G; Tiraboschi G; Furci L; Porri MT; Ravelli M; Lupo A
    Clin Nephrol; 1987 Jul; 28(1):1-9. PubMed ID: 3621685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acute and chronic renal failure in patients with myeloma].
    Biriukova LS; Volodiaeva EB; Fetisova EV; Pivnik AV; Margolin OV
    Ter Arkh; 1999; 71(7):58-64. PubMed ID: 10481869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plasmapheresis as a co-treatment in acute renal failure secondary to myeloma kidney].
    Levy F; Camarero Temiño V; Torres Torres G; Hijazi Prieto B
    Nefrologia; 2009; 29(3):283-4. PubMed ID: 19554076
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of renal insufficiency in patients with multiple myeloma].
    Vulić D; Radlović O; Stanojcić A; Radmilović A; Rajić M
    Srp Arh Celok Lek; 1996; 124 Suppl 1():53-5. PubMed ID: 9102930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmapheresis and hemodialysis in the treatment of acute renal failure in multiple myeloma.
    Kes P; Pecanić Z; Getaldić B
    Acta Med Croatica; 1995; 49(1):39-42. PubMed ID: 7633177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal failure in multiple myeloma. Pathogenesis and prognostic implications.
    Alexanian R; Barlogie B; Dixon D
    Arch Intern Med; 1990 Aug; 150(8):1693-5. PubMed ID: 2383164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous stem cell transplantation in multiple myeloma: outcome in patients with renal failure.
    Knudsen LM; Nielsen B; Gimsing P; Geisler C
    Eur J Haematol; 2005 Jul; 75(1):27-33. PubMed ID: 15946307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Renal insufficiency in myelomatosis. Causes and treatment].
    Knudsen LM; Hansen MT; Hippe E; Løkkegaard H
    Ugeskr Laeger; 1993 Nov; 155(47):3823-7. PubMed ID: 8256382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term survival patients with acute and severe renal failure due to multiple myeloma.
    Pasquali S; Casanova S; Zucchelli A; Zucchelli P
    Clin Nephrol; 1990 Dec; 34(6):247-54. PubMed ID: 2073767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermediate-dose (25mg/m2) IV melphalan for multiple myeloma with renal failure.
    Vigneau C; Ardiet C; Bret M; Laville M; Fiere D; Tranchand B; Fouque D
    J Nephrol; 2002; 15(6):684-9. PubMed ID: 12495285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of the patient with multiple myeloma and renal failure.
    Warwicker P; Summerfield G; Cove-Smith R
    Br J Hosp Med; 1994 Jun 1-14; 51(11):582-8. PubMed ID: 7952747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with multiple myeloma and renal insufficiency.
    Ballester OF; Tummala R; Janssen WE; Fields KK; Hiemenz JW; Goldstein SC; Perkins JB; Sullivan DM; Rosen R; Sackstein R; Zorsky P; Saez R; Elfenbein GJ
    Bone Marrow Transplant; 1997 Oct; 20(8):653-6. PubMed ID: 9383228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acute renal insufficiency in myeloma].
    Ragni R; Stratta P; Martini PF; Fruttero B; Piccoli G; Vercellone A
    Minerva Nefrol; 1973; 20(3):162-9. PubMed ID: 4761427
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 30.